10 April 2019
Biologists in Novosibirsk, in Siberia, have developed special nanoparticles that are said to be able to lower blood pressure, and are reported to have successfully tested the drug candidate on hypertension afflicted rats.
In a recent update Asya Levina, a researcher at the Novosibirsk State University (NSU), was quoted as saying that their solution is a system that consists of nanoparticles and short DNA molecules. “The former help the latter enter cells and bond with messenger ribonucleic acid (mRNA), thus preventing protein from forming. That results in no increase in the number of receptors on the cells, and the patient does not develop arterial hypertension.”
Reports by the World Health Organization (WHO) list cardiovascular diseases, including infarcts, strokes and chronic heart failures, as the number one natural killer globally. The diseases claim about 17 million people each year, and most of the victims hit their death road by developing chronic high blood pressure.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
New breast cancer guidelines call for first mammogram at age 40 but stop short of annual screening
08 May 2024
WHO proposes recommendations for preventing nitrosamine contamination
07 May 2024
Batyr Berdyklychev is now head of the WHO office in Russia
07 May 2024
Russia expects more medical tourism due to the world’s first drug for ankylosing spondylitis
07 May 2024